Juno and the FDA screwed up. People died. What now?
Let’s say it plain and simple: Juno Therapeutics $JUNO and the FDA screwed up and patients died.
The day ahead of Thanksgiving, Juno managed to once again stun its investors with the news that its lead CAR-T, JCAR015, killed two people. They died from cerebral edemas triggered by neurotoxicity. And the death toll from brain swelling triggered by its toxic combo has now reached six, including a death in a separate study.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.